tiprankstipranks
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
Japanese Market
2395
Shin Nippon Biomedical Laboratories, Ltd.
RESEARCH TOOLSreports
Want to see JP:2395 full AI Analyst Report?

Shin Nippon Biomedical Laboratories, Ltd. (2395) Income Statement

2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Income Statement

Last quarter (Q1 2025), Shin Nippon Biomedical Laboratories, Ltd.'s total revenue was ¥6.48B, an increase of 16.72% from the same quarter last year. In Q1, Shin Nippon Biomedical Laboratories, Ltd.'s net income was ¥260.42M. See Shin Nippon Biomedical Laboratories, Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 32.52B¥ 32.41B¥ 26.45B¥ 25.09B¥ 17.75B
Gross Profit
¥ 15.83B¥ 16.57B¥ 14.28B¥ 13.05B¥ 9.69B
Operating Expenses
¥ 13.17B¥ 13.59B¥ 10.12B¥ 7.80B¥ 5.49B
Depreciation and Amortization
¥ 3.43B¥ 2.61B¥ 1.87B¥ 1.60B¥ 1.18B
EBITDA
¥ 6.09B¥ 8.83B¥ 8.98B¥ 9.49B¥ 9.49B
Operating Income
¥ 2.65B¥ 2.99B¥ 4.16B¥ 5.25B¥ 4.20B
Other Income/Expenses
¥ 3.59B¥ 3.03B¥ 2.81B¥ 2.51B¥ 3.99B
Pretax Income
¥ 6.25B¥ 6.01B¥ 6.97B¥ 7.76B¥ 8.18B
Net Income
¥ 4.57B¥ 4.92B¥ 5.53B¥ 6.06B¥ 7.13B
Per Share Metrics
Basic EPS
¥ 109.69¥ 118.30¥ 132.86¥ 145.57¥ 171.21
Diluted EPS
¥ 109.69¥ 118.30¥ 132.86¥ 145.57¥ 171.21
Weighted Average Shares Outstanding
 41.63M 41.63M 41.63M 41.63M 41.63M
Weighted Average Shares Outstanding (Diluted)
 41.63M 41.63M 41.63M 41.63M 41.63M
Currency in JPY

Shin Nippon Biomedical Laboratories, Ltd. Earnings and Revenue History